fosifloxuridine nafalbenamide
nucana
['nuc-3373', '$ncna', 'nucana']
 these data are highly supportive of our strategy to develop nuc-3373 as a replacement for 5-fu, one of the most widely used medicines for the treatment of patients with #cancer. hugh s. griffith, nucana s founder and ceo learn more: #esmo22 $ncna 
NuCana is a clinical-stage biopharmaceutical company developing an expansive portfolio of new medicines to treat cancer.